BioVaxys Technology Corp. Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with Horizon Technology Finance Corp

Reuters

05-30

<a href="https://laohu8.com/S/BVAXF">BioVaxys Technology Corp.</a> Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with <a href="https://laohu8.com/S/HTFB">Horizon Technology Finance Corp</a>

BioVaxys Technology Corp. has announced an update to its Asset Purchase Agreement $(APA)$ with Horizon Technology Finance Corporation concerning the acquisition of former IMV Inc. assets. The amended agreement, dated May 29, 2025, reduces the capital raise milestone required from USD $10 million to USD $2,028,636, which must be met by September 30, 2025. Additionally, BioVaxys will issue share purchase warrants to Horizon and Powerscourt Investments XXV LP as part of the consideration. The Licensing Earn-Out Payments Term has also been extended to August 11, 2033. All other terms of the APA remain unchanged. This announcement reflects BioVaxys's ongoing efforts to finalize the acquisition formalized in February 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biovaxys Technology Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN99481) on May 30, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2539297433"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2539297433\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2539297433?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-30 08:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539297433","market":"us","top_or_hot":-1,"title":"BioVaxys Technology Corp. Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with Horizon Technology Finance Corp","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/BVAXF\">BioVaxys Technology Corp.</a> Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with <a href=\"https://laohu8.com/S/HTFB\">Horizon Technology Finance Corp</a>\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        BioVaxys Technology Corp. has announced an update to its Asset Purchase Agreement <a href=\"https://laohu8.com/S/APA\">$(APA)$</a> with <a href=\"https://laohu8.com/S/HTFA\">Horizon Technology Finance Corporation</a> concerning the acquisition of former <a href=\"https://laohu8.com/S/IMVIF\">IMV Inc.</a> assets. The amended agreement, dated May 29, 2025, reduces the capital raise milestone required from USD $10 million to USD $2,028,636, which must be met by September 30, 2025. Additionally, BioVaxys will issue share purchase warrants to Horizon and Powerscourt Investments XXV LP as part of the consideration. The Licensing Earn-Out Payments Term has also been extended to August 11, 2033. All other terms of the APA remain unchanged. This announcement reflects BioVaxys's ongoing efforts to finalize the acquisition formalized in February 2024.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biovaxys Technology Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN99481) on May 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioVaxys Technology Corp. Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with Horizon Technology Finance Corp</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioVaxys Technology Corp. Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with Horizon Technology Finance Corp\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-30 08:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/BVAXF\">BioVaxys Technology Corp.</a> Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with <a href=\"https://laohu8.com/S/HTFB\">Horizon Technology Finance Corp</a>\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        BioVaxys Technology Corp. has announced an update to its Asset Purchase Agreement <a href=\"https://laohu8.com/S/APA\">$(APA)$</a> with <a href=\"https://laohu8.com/S/HTFA\">Horizon Technology Finance Corporation</a> concerning the acquisition of former <a href=\"https://laohu8.com/S/IMVIF\">IMV Inc.</a> assets. The amended agreement, dated May 29, 2025, reduces the capital raise milestone required from USD $10 million to USD $2,028,636, which must be met by September 30, 2025. Additionally, BioVaxys will issue share purchase warrants to Horizon and Powerscourt Investments XXV LP as part of the consideration. The Licensing Earn-Out Payments Term has also been extended to August 11, 2033. All other terms of the APA remain unchanged. This announcement reflects BioVaxys's ongoing efforts to finalize the acquisition formalized in February 2024.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biovaxys Technology Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN99481) on May 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HRZN","symbol_name":"Horizon Technology Finance Corpo","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL4XYwbw:1","article_id":"2539297433","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539297433","pubTimestamp":1748565645,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BioVaxys Technology Corp. Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with Horizon Technology Finance Corp. BioVaxys Technology Corp. has announced an update to its Asset Purchase Agreement  with Horizon Technology Finance Corporation concerning the acquisition of former IMV Inc. assets. The amended agreement, dated May 29, 2025, reduces the capital raise milestone required from USD $10 million to USD $2,028,636, which must be met by September 30, 2025. Additionally, BioVaxys will issue share purchase warrants to Horizon and Powerscourt Investments XXV LP as part of the consideration. The Licensing Earn-Out Payments Term has also been extended to August 11, 2033. All other terms of the APA remain unchanged. This announcement reflects BioVaxys's ongoing efforts to finalize the acquisition formalized in February 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and t","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HRZN":"Horizon Technology Finance Corpo","BK4139":"生物科技","IMVIF":"IMV Inc.","BK4135":"资产管理与托管银行"},"translate_title":"BioVaxys Technology Corp.降低了与Horizon Technology Finance Corp修订后的资产购买协议中的融资里程碑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HRZN":0.9,"IMVIF":0.9},"content_text":"BioVaxys Technology Corp. Lowers Capital Raise Milestone in Amended Asset Purchase Agreement with Horizon Technology Finance Corp\n\n\n        BioVaxys Technology Corp. has announced an update to its Asset Purchase Agreement $(APA)$ with Horizon Technology Finance Corporation concerning the acquisition of former IMV Inc. assets. The amended agreement, dated May 29, 2025, reduces the capital raise milestone required from USD $10 million to USD $2,028,636, which must be met by September 30, 2025. Additionally, BioVaxys will issue share purchase warrants to Horizon and Powerscourt Investments XXV LP as part of the consideration. The Licensing Earn-Out Payments Term has also been extended to August 11, 2033. All other terms of the APA remain unchanged. This announcement reflects BioVaxys's ongoing efforts to finalize the acquisition formalized in February 2024.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biovaxys Technology Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN99481) on May 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}